Canton Strategic Holdings (CNTN) Current Assets (2020 - 2026)
Canton Strategic Holdings posted quarterly Current Assets of $43.1 million for Q1 2026, up 2493.48% year-on-year from $1.7 million in Q1 2025, and up 147.81% on a QoQ basis from $17.4 million in Q4 2025.
Canton Strategic Holdings (CNTN) has 7 years of Current Assets data on file, last reported at $43.1 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 2493.48% year-over-year to $43.1 million; the trailing twelve-month figure through Mar 2026 stood at $43.1 million (up 2493.48% YoY), and the FY2025 full-year result was $17.4 million, up 367.16% from the prior year.
- Current Assets for Q1 2026 stood at $43.1 million, up from $17.4 million in the prior quarter.
- Across five years, Current Assets topped out at $43.1 million in Q1 2026 and bottomed at $1.7 million in Q1 2025.
- The 5-year median for Current Assets is $7.7 million (2025), against an average of $9.4 million.
- The widest annual swing landed in 2025, when Current Assets slumped 81.31%; it then jumped 2493.48% in 2026.
- A 5-year view of Current Assets shows it stood at $6.7 million in 2022, then soared by 63.66% to $10.9 million in 2023, then tumbled by 66.0% to $3.7 million in 2024, then surged by 367.16% to $17.4 million in 2025, then surged by 147.81% to $43.1 million in 2026.
- The last three Current Assets figures came in at $43.1 million (Q1 2026), $17.4 million (Q4 2025), and $7.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - | 43.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.09 Mn |
| Dec 31, 2025 | 17.39 Mn |
| Sep 30, 2025 | 7.70 Mn |
| Jun 30, 2025 | 2.53 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | 3.72 Mn |
| Sep 30, 2024 | 5.25 Mn |
| Jun 30, 2024 | 8.26 Mn |
| Mar 31, 2024 | 8.89 Mn |
| Dec 31, 2023 | 10.95 Mn |
| Sep 30, 2023 | 3.17 Mn |
| Jun 30, 2023 | 4.60 Mn |
| Mar 31, 2023 | 4.72 Mn |
| Dec 31, 2022 | 6.69 Mn |
| Sep 30, 2022 | 8.02 Mn |
| Jun 30, 2022 | 10.25 Mn |
| Mar 31, 2022 | 12.09 Mn |
| Dec 31, 2021 | 621,677.00 |
| Dec 31, 2020 | 294,798.00 |